JP2017523142A5 - - Google Patents

Download PDF

Info

Publication number
JP2017523142A5
JP2017523142A5 JP2016572533A JP2016572533A JP2017523142A5 JP 2017523142 A5 JP2017523142 A5 JP 2017523142A5 JP 2016572533 A JP2016572533 A JP 2016572533A JP 2016572533 A JP2016572533 A JP 2016572533A JP 2017523142 A5 JP2017523142 A5 JP 2017523142A5
Authority
JP
Japan
Prior art keywords
composition according
range
surfactant
macrogol
particle size
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016572533A
Other languages
English (en)
Japanese (ja)
Other versions
JP6634034B2 (ja
JP2017523142A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IN2015/000266 external-priority patent/WO2015198350A1/en
Publication of JP2017523142A publication Critical patent/JP2017523142A/ja
Publication of JP2017523142A5 publication Critical patent/JP2017523142A5/ja
Application granted granted Critical
Publication of JP6634034B2 publication Critical patent/JP6634034B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016572533A 2014-06-25 2015-06-25 医薬水中油型ナノエマルジョン Expired - Fee Related JP6634034B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN3077CH2014 2014-06-25
IN3077/CHE/2014 2014-06-25
PCT/IN2015/000266 WO2015198350A1 (en) 2014-06-25 2015-06-25 A pharmaceutical oil-in-water nano-emulsion

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019189623A Division JP2020037557A (ja) 2014-06-25 2019-10-16 医薬水中油型ナノエマルジョン

Publications (3)

Publication Number Publication Date
JP2017523142A JP2017523142A (ja) 2017-08-17
JP2017523142A5 true JP2017523142A5 (enExample) 2018-07-05
JP6634034B2 JP6634034B2 (ja) 2020-01-22

Family

ID=54015153

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016572533A Expired - Fee Related JP6634034B2 (ja) 2014-06-25 2015-06-25 医薬水中油型ナノエマルジョン
JP2019189623A Pending JP2020037557A (ja) 2014-06-25 2019-10-16 医薬水中油型ナノエマルジョン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019189623A Pending JP2020037557A (ja) 2014-06-25 2019-10-16 医薬水中油型ナノエマルジョン

Country Status (4)

Country Link
US (1) US10736842B2 (enExample)
EP (1) EP3160444B1 (enExample)
JP (2) JP6634034B2 (enExample)
WO (1) WO2015198350A1 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0610308A8 (pt) 2005-05-26 2017-04-25 Neuron Systems Inc Composições e métodos para o tratamento de doença retinal
US9814701B2 (en) 2009-12-11 2017-11-14 Aldeyra Therapeutics, Inc. Compositions and methods for the treatment of macular degeneration
CN105120866B (zh) 2013-01-23 2020-02-14 奥尔德拉医疗公司 与毒性醛相关的疾病和治疗
US11400048B2 (en) * 2014-06-25 2022-08-02 Synergia Bio Sciences Private Limited Pharmaceutical oil-in-water nano-emulsion
WO2017035077A1 (en) 2015-08-21 2017-03-02 Aldeyra Therapeutics, Inc. Deuterated compounds and uses thereof
CA3022665A1 (en) 2016-05-09 2017-11-16 Aldeyra Therapeutics, Inc. Combination treatment of ocular inflammatory disorders and diseases
AU2017277497B2 (en) * 2016-06-07 2023-05-04 Northeastern University Nanoemulsion compositions of taxoid drugs, and methods for the use thereof to target cancer cells and cancer stem cells
JP7100635B2 (ja) 2016-11-02 2022-07-13 セントレクシオン セラピューティクス コーポレイション 安定な水性カプサイシン注射製剤およびその医学的使用
WO2018115932A1 (en) * 2016-12-21 2018-06-28 Dukebox Sp. Z O. O. A method of manufacturing a water-in-oil emulsion of nanoparticles of paracetamol
IL272036B2 (en) 2017-07-20 2025-01-01 Centrexion Therapeutics Corp Methods and compositions for treating pain using capsaicin
CN111356451A (zh) 2017-10-10 2020-06-30 奥尔德拉医疗公司 炎性病症的治疗
AU2019205329B2 (en) 2018-01-05 2023-04-20 Impel Pharmaceuticals Inc. Intranasal delivery of olanzapine by precision olfactory device
JP7385881B2 (ja) * 2018-07-18 2023-11-24 テクノガード株式会社 オキシカム系薬物含有注射剤
WO2020028820A1 (en) * 2018-08-03 2020-02-06 Aldeyra Therapeutics, Inc. Topical compositions and methods of preparation and use
US12006298B2 (en) 2018-08-06 2024-06-11 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
US11690963B2 (en) 2018-08-22 2023-07-04 Qnovia, Inc. Electronic device for producing an aerosol for inhalation by a person
US11517685B2 (en) 2019-01-18 2022-12-06 Qnovia, Inc. Electronic device for producing an aerosol for inhalation by a person
EP3829370A4 (en) 2018-08-22 2022-04-27 Respira Technologies, Inc. Electronic device for producing an aerosol for inhalation by a person
US12472103B2 (en) 2018-11-21 2025-11-18 Bocannaveda, Llc Nano-emulsified cannabinoid or oils in athletic tape and other products
CN113365590A (zh) * 2018-11-21 2021-09-07 博坎纳维达有限责任公司 透气带及其它产品中的经纳米乳化的大麻素或油
GB201904771D0 (en) 2019-04-04 2019-05-22 Orexo Ab New pharmaceutical compositions
US12098132B2 (en) 2019-05-02 2024-09-24 Aldeyra Therapeutics, Inc. Process for preparation of aldehyde scavenger and intermediates
CA3137301A1 (en) 2019-05-02 2020-11-05 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
JP7569336B2 (ja) * 2019-06-11 2024-10-17 サイファイ エス.ピー.エー. マイクロエマルション組成物
TW202128132A (zh) * 2019-10-20 2021-08-01 美商瑞斯比拉科技公司 使用電子裝置進行霧化及吸入之液體
US20210113783A1 (en) * 2019-10-20 2021-04-22 Respira Technologies, Inc. Electronic devices and liquids for aerosolizing and inhaling therewith
EP4149470A4 (en) 2020-05-13 2024-04-24 Aldeyra Therapeutics, Inc. Pharmaceutical formulations and uses thereof
US12471625B2 (en) 2020-11-01 2025-11-18 Qnovia, Inc. Electronic devices and liquids for aerosolizing and inhaling therewith
WO2023205385A1 (en) 2022-04-22 2023-10-26 Qnovia, Inc. Electronic devices for aerosolizing and inhaling liquid

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2646773B1 (fr) * 1989-05-12 1994-05-13 Chauvin Sa Laboratoire Composition pharmaceutique a base de paracetamol
US5744155A (en) 1993-08-13 1998-04-28 Friedman; Doron Bioadhesive emulsion preparations for enhanced drug delivery
UA44838C2 (uk) 1996-03-25 2002-03-15 Елі Ліллі Енд Компані Спосіб лікування мігрені
ATE497384T1 (de) * 1997-12-10 2011-02-15 Cyclosporine Therapeutics Ltd Omega-3 fettsäure enthaltende pharmazeutische zusammensetzungen
AU3843999A (en) 1998-05-07 1999-11-23 Elan Corporation, Plc Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems
GB9823246D0 (en) 1998-10-24 1998-12-16 Danbiosyst Uk A nasal drug delivery composition
US20030044356A1 (en) * 2001-04-20 2003-03-06 Jin Auh Composition for nasal solution sprays having effective component of 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one)
GB0116107D0 (en) 2001-06-30 2001-08-22 West Pharm Serv Drug Res Ltd Pharmaceutical composition
KR100425755B1 (ko) 2001-08-27 2004-04-03 주식회사 원진신약 이트라코나졸을 함유하는 조성물 및 그 제조방법
IL164163A0 (en) 2002-04-09 2005-12-18 Pharmacia Corp Process for preparing a finely self-emulsifiable pharmaceutical composition
US20060210500A1 (en) * 2003-04-18 2006-09-21 Merck Patent Gmbh Formulations
IL181217A0 (en) * 2007-02-08 2007-07-04 Haim Levy Pharmaceuticalcompositions based on a microemulsion
CN101524329B (zh) 2007-09-20 2014-09-03 中国医学科学院药物研究所 双环醇亚微乳及其制备方法
CN101780037B (zh) 2010-02-03 2011-11-16 南昌大学 双嘧达莫自乳化给药系统及其制备方法

Similar Documents

Publication Publication Date Title
JP2017523142A5 (enExample)
US11020375B2 (en) Edaravone dosage form
JP5726067B2 (ja) 難透過性医薬品活性成分のための改善された製剤
JP2020037557A (ja) 医薬水中油型ナノエマルジョン
JP6670283B2 (ja) タペンタドールを含む半固形の水性医薬組成物
EP3481381B1 (en) Oral dosage form with drug composition, barrier layer and drug layer
JP2009514890A (ja) テトラヒドロカンナビノールの改良された送達
JP5966228B2 (ja) アリピプラゾール組成物
US20210346302A1 (en) Pharmaceutical Formulation
CN1543359A (zh) 可生物利用的口服剂型醋氯芬酸组合物及其制备方法
US10973761B2 (en) Pharmaceutical formulation
TW200840596A (en) Microemulsion dosage forms of valsartan and methods of making the same
CN111465412A (zh) Nk-1拮抗剂的口服药物组合物
CN106727382A (zh) 一种卡维地洛过饱和自微乳分散片及其制备方法
JP5503939B2 (ja) アゼラスチン塩酸塩含有カプセル剤
KR20250129103A (ko) 자가유화 약학적 조성물, 그 제조 방법 및 그 용도
JP2017518980A (ja) タペンタドールを含む、改変防止即時放出カプセル製剤
US20250032520A1 (en) Oral cannabinoid compositions and methods for treating neurological diseases and disorders
EP3135299A1 (en) Active ingredient (i) containing composition and method for preparing same
Pires et al. Antipsychotics-loaded Nanometric emulsions for brain delivery. Pharmaceutics. 2022; 14: 2174
KR20190032265A (ko) 약제학적 제형
TR2021012699A2 (tr) Cannabi̇di̇olün nazal uygulanan kolloi̇dal formülasyonlari
HK40008934B (en) Oral dosage form with drug composition, barrier layer and drug layer
HK40008934A (en) Oral dosage form with drug composition, barrier layer and drug layer
TW200936128A (en) Pharmaceutical compositions based on azetidine derivatives